Predicting outcome and survival in patients with Wegener's granulomatosis treated on the intensive care unit

Scandinavian Journal of Rheumatology

Volumn 36, Issue 2, 2007, Pages 119-124

  Burkhardt, O ^a,b   Kohnlein T ^a,b   Wrenger, E ^a   Lux, A ^a   Neumann, K H ^a   Welte, T ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE;

ACUTE KIDNEY FAILURE; ADULT; AGED; APACHE; ARTICLE; BRAIN HEMORRHAGE; CONFIDENCE INTERVAL; CONTINGENCY TABLE; CREATININE BLOOD LEVEL; DISCRIMINANT ANALYSIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMODIALYSIS; HEMOPTYSIS; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LOGISTIC REGRESSION ANALYSIS; LUNG EMBOLISM; MALE; MORTALITY; PRIORITY JOURNAL; RESPIRATORY FAILURE; RISK; RISK FACTOR; SEPSIS; SURVIVAL; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; UNIVERSITY HOSPITAL; WEGENER GRANULOMATOSIS;

ADULT; AGED; APACHE; FEMALE; GERMANY; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; WEGENER GRANULOMATOSIS;

EID: 34247558198     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740600958611     Document Type: Article

References (30)

1. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;31:187-92.
2. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
3. Jayne DR. Pulmonary-renal syndrome. Semin Resp Crit Care Med 1998;19:69-77.
4. Niles JL, Bottinger EP, Saurina GR, Kelly KJ, Pan G, Collins AB, et al. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 1996;156:440-5.
5. Walton EW. Giant cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J 1958;2:265-70.
6. Fauci AS, Barton FH, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
7. Koldingsnes W, Nossent H. Predictors of survival and organ damage in Wegener's garnulomatosis. Rheumatology 2002;41:572-81.
8. Briedigkeit L, Kettritz R, Gobel O, Natusch R. Prognostic factors in Wegener's granulomatosis. Postgrad Med J 1993;69:856-61.
9. Luqmani RA, Bacon PA, Beaman M, Scott DG, Emery P, Lee SJ, et al. Classical versus non-renal Wegener's granulomatosis. Q J Med 1994;87:161-7.
10. Westman KW, Bygren PG, Olsson H, Ranstam J, Wieslander J. Relapse rate, renal survival and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 1998;9:842-52.
11. Aasarod K, Iversen BM, Hammerstrom J, Bostad L, Vatten L, Jorstad S. Wegener's granulomatosis: clinical course in 108 patients with renal involvement. Nephrol Dial Transplant 2000;15:611-18.
12. Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nolle B, et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 2000;43:1021-32.
13. Mahr A, Girard T, Agher R, Guillevin L. Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up. Rheumatology 2001;40:492-8.
14. Bligny D, Mahr A, Toumelin PL, Mouthon L, Guillevin L. Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients. Arthritis Rheum 2004;51:83-91.
15. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
16. Kollef MH, Enzenauer RJ. Predicting outcome from intensive care for patients with rheumatologic diseases. J Rheumatol 1992;19:1260-2.
17. Godeau B, Boudjadja A, Dhainaut JF, Schlemmer B, Chastang C, Brunet F, et al. Outcome of patients with systemic rheumatic disease admitted to medical intensive care units. Ann Rheum Dis 1992;51:627-31.
18. Godeau B, Mortier E, Roy PM, Chevret S, Bouachour G, Schlemmer B, et al. Short- and long-term outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients. J Rheumatol 1997;24:1317-23.
19. Thong BY, Tai DY, Goh SK, Johan A. An audit of patients with rheumatic disease requiring medical intensive care. Ann Acad Med Singapore 2001;30:254-9.
20. Alzeer AH, Al-Arfaj A, Basha SJ, Alballa S, Al-Wakeel J, Al-Arfaj H, et al. Outcome of patients with systemic lupus erythematosus in intensive care unit. Lupus 2004;13:537-42.
21. Camargo JF, Tobon GJ, Fonseca N, Diaz JL, Uribe M, Molina F, et al. Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature. Lupus 2005;14:315-20.
22. Moreels M, Mélot C, Leeman M. Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit. Intensive Care Med 2005;31:591-3.
23. Cruz BA, Ramanoelina J, Mahr A, Cohen P, Mouthon L, Cohen Y, et al. Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit. Rheumatology 2003;42:1183-8.
24. Lauter J. Stable Decisions in Discriminant, Regression and Factor Analysis. In Fedorov V, Lauter H, editors. Model Oriented Data Analysis. Lecture Notes in Economics and Mathematical Systems 297. Berlin: Springer, 1987: 181-88.
25. Loh WL. Linear discrimination with adaptive ridge classification rules. J Multivar Anal 1997;62:169-80.
26. Oh TE, Hutchinson R, Short S, Buckley T, Lin E, Leung D. Verification of the Acute Physiology and Chronic Health Evaluation scoring system in a Hong Kong intensive care unit. Crit Care Med 1993;21:698-705.
27. Wong DT, Crofts SL, Gomez M, McGuire GP, Byrick RJ. Evaluation of predictive ability of APACHE II system and hospital outcome in Canadian intensive care unit patients. Crit Care Med 1995;23:1177-83.
28. King DA, Codish S, Novack V, Barski L, Almog Y. The role of cardiac troponin I as a prognosticator in critically ill medical patients: a prospective observational cohort study. Crit Care 2005;9:390-5.
29. Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997;40:2187-98.
30. Langford CA, Talar-Williams C, Barron KS, Sneller MC. Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse. Am J Med 2003;114:463-9.